Optimise your clinical trials with Avantor Clinical Services
December 1, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2020 Campaign, Avantor, clinical trials, expertise
Serious diseases like COVID-19 put increasing pressure on researchers to find breakthrough treatments faster. Along with accelerated timelines, biopharma and …
Cabometyx scores Japanese approval for unresectable hepatocellular carcinoma patients following systemic therapy
November 30, 2020Sales and Marketing Cabometyx, Japan, Takeda
The Japanese Ministry of Health, Labor and Welfare has awarded approval to Takeda for Cabometyx (cabozantinib) as a treatment for …
Analysis confirms Moderna’s COVID-19 vaccine efficacy to be 94.1%
November 30, 2020Research and Development, Sales and Marketing COVID-19, Moderna, Vaccine
US biotech Moderna has followed up on its highly promising efficacy data for its mRNA-based COVID-19 vaccine candidate with the …
Dupixent becomes first systemic medicine approved in Europe for children with severe atopic dermatitis
November 30, 2020Sales and Marketing Dupixent, EU, Europe, Sanofi
The European Commission has moved to expand the existing authorisation of Sanofi and Regeneron’s Dupixent (dupilumab) in the European Union …
UK secures another two million COVID-19 vaccine doses from Moderna
November 30, 2020Sales and Marketing COVID-19, Moderna, UK
The UK Government has expanded upon its previous negotiations with Moderna to secure an additional two million doses of its …
Japan approves AstraZeneca’s Forxiga for chronic heart failure
November 30, 2020Sales and Marketing AstraZeneca, Forxiga
Japan’s Ministry of Health, Labour and Welfare (MHLW) has announced the authorisation of AstraZeneca’s Forxiga as a treatment for chronic …
AstraZeneca targeted by suspected North Korean hackers
November 27, 2020Medical Communications
Hackers suspected to be operating from North Korea have tried to break into the systems of AstraZeneca, two people with …
Japan approves Astellas and FibroGen’s Evrenzo for chronic kidney disease patients currently not receiving dialysis
November 27, 2020Medical Communications, Sales and Marketing Astellas, Japan, fibrogen
Japan’s Ministry of Health, Labour and Welfare (MHLW) has passed approval for Astellas and FibroGen’s Evrenzo (roxadustat) in the treatment …
New trial expected for AstraZeneca’s COVID-19 vaccine
November 27, 2020Medical Communications
AstraZeneca is expected to launch new global trials to assess the efficacy of its COVID-19 vaccine using a lower dosage. …
EU fines Teva and Cephalon for keeping cheap sleep disorder medicine off the market
November 27, 2020Medical Communications
The European Union has fined Teva and Cephalon for colluding to keep a cheap alternative sleep disorder medicine off the …
Top Ten most popular articles on Pharmafile.com this week
November 27, 2020Medical Communications
The top ten news stories this week once again focus on COVID-19 treatments, with the Canadian Government securing 26,000 doses …
Y-mAbs announces FDA approval of Danyelza for the treatment of Neuroblastoma
November 26, 2020Business Services
Y-mAbs Therapeutics has announced that the FDA has approved Danyelza in combination with granulocyte-macrophage colony-stimulating factor (“GM-CSF”), for the treatment …
England COVID-19 spread levelling off after cases fell slightly
November 26, 2020Business Services
Coronavirus infection rates across England are levelling off after a slight decrease in cases last week, according to the Office …
Plan to import Canadian drugs to the US challenged by pharmaceutical lobby in Florida
November 26, 2020Business Services
The proposed plan to import cheaper Canadian drugs to Florida is being challenged by the US pharmaceutical lobby in court. …
FDA approves first drug to treat rare rapid ageing condition progeria
November 26, 2020Business Services
The FDA has approved the first drug to treat the rare genetic disorder progeria, a rare condition which causes cells …
Philippines poised to secure two million AstraZeneca COVID-19 vaccine doses
November 26, 2020Manufacturing and Production AstraZeneca, COVID-19, Vaccine
The Philippines is set to imminently seal a deal with AstraZeneca for two million doses of AstraZeneca’s COVID-19 vaccine, it …
Canada secures 26,000 doses of Lilly therapy to treat COVID-19 in $32.5m deal
November 25, 2020Manufacturing and Production, Research and Development COVID-19, Canada
The Canadian Government has partnered up with Eli Lilly to secure 26,000 doses of the company’s monoclonal antibody therapy bamlanivimab …
Largest clinical trial treating mild to moderate COVID-19 patients to take place in Africa
November 25, 2020Research and Development
The world’s largest clinical trial investigating the treatment of patients with mild to moderate COVID-19 is set to begin in …
ABPI warns that no-deal Brexit could disrupt medicines and vaccine delivery
November 25, 2020Research and Development
The Association of the British Pharmaceutical Industry (ABPI) has warned that the supplies of crucial medicines and vaccines could be …
Purdue Pharma pleads guilty to its role in the opioid crisis
November 25, 2020Research and Development
Purdue Pharma has pleaded guilty to criminal charges over its role in fueling the opioid crisis which was driven by …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
